77 search results for: pediatric

Missing material
Content temporarily unavailable
SPD | Shifting Gears: Can Disease Course Be Changed in Patients With Pediatric Atopic Dermatitis?

Join experts Drs. Amy Paller and Peter Lio at an educational symposium as they investigate atopic dermatitis as a risk factor for the development of food allergies. The speakers will also discuss the benefits of early intervention in pediatric atopic dermatitis and the potential for disease modification.

Missing material
Content temporarily unavailable
GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age

Explore GINA-based recommendations for identifying risk factors, optimizing management plans, and monitoring disease progression in pediatric asthma.

Missing material
Content temporarily unavailable
ADVENT at EAACI PAAM 2025

Join Sanofi and Regeneron for ​an educational symposium on type 2 inflammation processes underlying pediatric asthma, atopic dermatitis,​ and eosinophilic esophagitis.

Missing material
Content temporarily unavailable
Unlocking Better Outcomes: Strategies for Early Diagnosis and Effective Management in Pediatric EoE Patients

Pediatric gastroenterology experts Dr Carolina Gutiérrez Junquera and Dr Christos Tzivinikos where they discuss the importance of early identification and management of pediatric EoE to improve long-term outcomes. They highlight clinical data and discuss their practical experiences with pediatric EoE, including their perspectives on co-occurring type 2 inflammatory diseases, the chronic nature of EoE, and the future of EoE research and therapeutic development.

Missing material
Content temporarily unavailable
ADVENT at ESPGHAN 2025 | Unlocking Better Outcomes: Strategies for Early Diagnosis and Effective Management in Pediatric EoE Patients

In support of World Eosinophilic Esophagitis Day, this ADVENT symposium features pediatric gastroenterology experts Dr Carolina Gutiérrez Junquera and Dr Christos Tzivinikos where they discuss the importance of early identification and management of pediatric EoE to improve long-term outcomes. They highlight clinical data and discuss their practical experiences with pediatric EoE, including their perspectives on co-occurring type 2 inflammatory diseases, the chronic nature of EoE, and the future of EoE research and therapeutic development.

Missing material
Content temporarily unavailable
ADVENT at ESPGHAN 2026 | Pediatric EoE: An Interactive Learning Symposium

Join leading experts in pediatric eosinophilic esophagitis (EoE), Professors Salvatore Oliva, MD, PhD, and André Hörning, MD, as they explore the multifaceted journey of pediatric patients with EoE through a hypothetical patient case, navigating real-world challenges in managing EoE.

Missing material
Content temporarily unavailable
Multifaceted Burden of Pediatric EoE

Hear from Prof. Papadopoulou as she discusses how EoE can impact different aspects of disease burden in pediatric patients and their caregivers.

Missing material
Content temporarily unavailable
The PEDISTAD Survey: Assessing the Burden of Atopic Dermatitis in the Global Pediatric Population

An interactive tool used to explore the global burden of atopic dermatitis in children and adolescents.

Missing material
Content temporarily unavailable
European Society for Pediatric Dermatology (ESPD) 2024 | Košice, Slovakia

Inflammatory processes drive AD both within and beyond the skin, leading to significant, cumulative life impacts. Early intervention has the potential to mitigate these impacts by altering the disease course.

Missing material
Content temporarily unavailable
American Academy of Allergy, Asthma, & Immunology (AAAAI) 2023 | San Antonio

Watch highlights from the AAAAI 2023 Conference in San Antonio, TX, USA.

Missing material
Content temporarily unavailable
Association of Younger Age of Onset With Persistence of AD

Dr. Paller presents the Pediatric Eczema Elective Registry (PEER) findings, which suggest early-onset of AD is associated with higher risk of persistence of disease.

Missing material
Content temporarily unavailable
Current systemic therapies have been shown to induce remission in a subset of AD patients

Dr. Ramien discusses evidence suggesting early targeted inhibition in pediatric patients may prevent disease progression or lead to remission.